DexTech Medical AB

DexTech Medical is a biotechnology research company. Today specialisation is in the area of urologic oncology, where common diseases include prostate cancer. A significant part of the research is carried out in collaboration with international players, research institutes and universities. The company was established in 2004 and is based in Uppsala.

Quotes for DexTech Medical AB

Right Now

+/-
-0.35
%
−4,67%
Latest
7.15
High
7.6
Low
7.15
Volume
1 662
Turnover (SEK)
12 057
Market Value (MSEK)
132,2
Time (Latest trade)
2025-07-01 09:58

Board

CEO

  • Anders Holmberg

Chairperson of the Board

  • Andreas Segerros

Board

  • Per-Olov Asplund
  • Peter Benson
  • Rolf Eriksson
  • Svante Wadman
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Hearing med DexTech

    Largest Owners

    Name Capital % Votes % Date
    Svante Wadman 21,45 21,45 2025-03-27
    Anders Holmberg 8,51 8,51 2025-03-27
    Sten Nilsson 7,75 7,75 2025-03-27
    Donald Ericsson Fastigheter VI AB 6,08 6,08 2025-03-27
    Gösta Lundgren 5,96 5,96 2025-03-27
    Hans Andersson med familj 5,60 5,60 2023-02-20
    Nordnet Pensionsförsäkring 3,56 3,56 2025-03-27
    Avanza Pension 3,46 3,46 2025-03-27
    Mats Ragnarsson Holmberg 2,32 2,32 2025-03-27
    Peter Kanekrans 2,07 2,07 2025-03-27
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2025-08-29 Bokslutskommuniké 2025

    • 2025-11-03 Delårsrapport 2026-Q1

    • 2025-11-04 Årsstämma 2025

    • 2026-02-25 Delårsrapport 2026-Q2

    • 2026-05-05 Delårsrapport 2026-Q3

    • 2026-08-31 Bokslutskommuniké 2026

    Annual reports, prospectus etc.